Evidence map›Paper›PMID 33896710›Full record

ArticleEuropean urology focus2021

Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging.

Teresa Marsden, Neil McCartan, Joanna Hadley, Steve Tuck, Louise Brown, Anna J Haire, Charlotte L Moss, Saran Green, Mieke Van Hemelrijck, Ton Coolen and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European urology focus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Teresa MarsdenUCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: teresa.marsden@ucl.ac.uk.
Neil McCartanUCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
Joanna HadleyUCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
Steve TuckReIMAGINE Consortium Patient Representative.
Louise BrownMRC Clinical Trials Unit, University College London, London, UK.
Anna J HaireTranslational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
Charlotte L MossTranslational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
Saran GreenTranslational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
Mieke Van HemelrijckTranslational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
Ton CoolenLondon Institute for Mathematical Sciences, London, UK.
Aida SantaolallaCancer Epidemiology Group, Division of Cancer Studies, King's College London School of Medicine, London, UK.
Elizabeth IsaacCentre for Medical Imaging, University College London, London, UK.
Giorgio BrembillaCentre for Medical Imaging, University College London, London, UK.
Douglas KopckeDepartment of Radiology, University College London Hospitals NHS Foundation Trust, London, UK.
Francesco GigantiUCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK.
Harbir SidhuCentre for Medical Imaging, University College London, London, UK.
Shonit PunwaniCentre for Medical Imaging, University College London, London, UK.
Mark EmbertonUCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
Caroline M MooreUCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
ReIMAGINE Study Group

Funding

Cancer Research UKMedical Research Council MC_UU_00004/01Medical Research Council MC_UU_00004/02Medical Research Council MC_UU_12023/28Medical Research Council MR/R014043/1
6 · The paper itself

Abstract

ReIMAGINE Screening is a single-centre study assessing the feasibility of biparametric magnetic resonance imaging as a screening tool for prostate cancer. The study outcomes will take us a step towards more accurate and less harmful prostate cancer screening.

Indexed as

Early Detection of CancerProstatic NeoplasmsHumansMagnetic Resonance ImagingMaleProstate-Specific AntigenProstate-Specific Antigen

Identifiers

PMID33896710
PMCPMC7614671

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.